Citigroup Sours on Block as Stock Tumbles Amidst Setbacks
Block stock has experienced setbacks, leading to Citigroup adjusting its perspective and revising price target. Despite challenges, Block remains resilient.
Cetera Financial Group: Genstar Capital Reinvests in Wealth Management Company
Cetera Financial Group receives reinvestment from Genstar Capital, fueling its growth and positioning itself as a leading player in the wealth management industry. Genstar announces additional investment in Cetera, expressing confidence in...
Bond Yields Surge to Multi-Year Highs
Bond yields reach multi-year highs, impacting company earnings and economic growth. Global markets affected.
Topps Tiles Expects Full-Year Profits to Meet Expectations
Topps Tiles expects to meet profit expectations and reports record revenue with strong market-share gains in the UK tiling market. Sales reached £263 million, marking a 6.4% increase compared to the previous year.
Zoom Unveils Zoom Docs to Compete with Microsoft and Google
Zoom announces the launch of Zoom Docs, a new word-processing application to compete with Microsoft Teams and Google Docs, offering advanced AI capabilities and seamless collaboration.
Millennials Outpacing Baby Boomers in Retirement Savings
Millennials are better prepared for retirement than baby boomers, thanks to factors like automatic enrollment and improved plan designs. Overall, younger generations have a positive outlook on saving for retirement.
Stock Market Update
Stay updated on the latest stock market movements, pre-market gains and declines, commodities news, and futures for major indices. Get a comprehensive overview.
Summit Midstream Partners Considers Strategic Alternatives
Summit Midstream Partners explores strategic alternatives, including potential sale, to maximize value. CEO optimistic about company's outlook.
Stocks Close Mixed as Government Debt Selloff Resumes
Stocks closed mostly higher as U.S. government debt selloff resumed, while Nasdaq Composite Index gained. Concerns over surging borrowing costs and debt rout impact.
FDA Sends Complete Response Letter to Eli Lilly for Atopic Eczema Treatment
The FDA has sent a response letter to Eli Lilly for their atopic eczema treatment. The stock experienced a slight dip, but remains optimistic about their diabetes treatment.